Ton Logtenberg

Outlook ServiceNow Microsoft Office 365 Google Cloud Hosting Drupal WP Engine Atlassian Cloud Google Tag Manager reCAPTCHA Nginx Vimeo Google Maps (Non Paid Users) Google Maps WordPress.org Gravity Forms Google Font API New Relic Hotjar Mobile Friendly Micro Circle Remote

immunooncology oncology immunology antibody engineering antibody discovery cell biology in vivo biomarker development early discovery protein production robotics functional assays biotechnology: pharmaceutical preparations health care biotechnology research cancer treatment multiclonics bispecific antibodies trispecific antibodies immuno-oncology clinical trials targeted therapy cancer therapies immune system activation drug development pipeline research collaboration egfr targeting lgr5 immune response immune modulation molecule binding therapeutic antibodies chemical entities biologics monoclonal antibodies preclinical studies antigen engagement tumor cells patient care biotech industry collaboration agreements drug candidates pharmaceutical partnerships clinical research therapeutics cancer antigens long half-life low immunogenicity target combinations oncology expertise anti-cancer effects treatment modalities immune landscape proprietary technology availability of therapy strategic relationship biopharmaceuticals tumor microenvironment drug approvals clinical-stage oncology antibody therapeutics biclonics triclonics immune system engagement innovative therapeutics petosemtamab cancer pipeline oncology market healthcare partnerships targeted therapies genetic profiles antibody-drug conjugates unmet medical needs patient-centric approach advanced malignancies research & development pharmaceutical collaborations cancer patients therapeutic precision drug discovery biotechnology treatment efficacy patient focus cancer therapeutics hospital & health care mechanical or industrial engineering information technology & services health wellness & fitness